Tenax Therapeutics (TENX) Other Accumulated Expenses (2016 - 2017)
Historic Other Accumulated Expenses for Tenax Therapeutics (TENX) over the last 3 years, with Q3 2017 value amounting to $170711.0.
- Tenax Therapeutics' Other Accumulated Expenses fell 9477.99% to $170711.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $170711.0, marking a year-over-year decrease of 9477.99%. This contributed to the annual value of $4.4 million for FY2016, which is N/A changed from last year.
- Per Tenax Therapeutics' latest filing, its Other Accumulated Expenses stood at $170711.0 for Q3 2017, which was down 9477.99% from $1.6 million recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Other Accumulated Expenses registered a high of $4.4 million during Q4 2016, and its lowest value of $170711.0 during Q3 2017.
- Over the past 3 years, Tenax Therapeutics' median Other Accumulated Expenses value was $3.3 million (recorded in 2016), while the average stood at $2.7 million.
- As far as peak fluctuations go, Tenax Therapeutics' Other Accumulated Expenses soared by 7043.3% in 2016, and later tumbled by 9477.99% in 2017.
- Quarter analysis of 3 years shows Tenax Therapeutics' Other Accumulated Expenses stood at $2.6 million in 2015, then soared by 70.43% to $4.4 million in 2016, then plummeted by 96.09% to $170711.0 in 2017.
- Its Other Accumulated Expenses stands at $170711.0 for Q3 2017, versus $1.6 million for Q2 2017 and $3.5 million for Q1 2017.